A trial looking at volrustomig for head and neck cancer that has spread into the surrounding tissue (eVOLVE-HNSCC)
This trial is looking at volrustomig (MEDI5752) for head and neck cancer that has spread into the surrounding tissue and cannot be removed by surgery.